COMMUNIQUÉS West-GlobeNewswire

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder

10/12/2018 - 21:43

reSET-O TM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics is leading the development of a new therapeutic class with two FDA-authorized PDTs and a [...]

Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Management and Employees in Genmab

10/12/2018 - 19:41

Company Announcement Copenhagen, Denmark; December 10, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 80,380 restricted stock units to members of the board [...]

Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018

10/12/2018 - 19:01

Pratteln, Switzerland, December 10, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that its Board of Directors will submit an amended proposal to its upcoming Extraordinary General Meeting on December 11, 2018. [...]

SunGen Pharma Receives US FDA Approval for Prednisone ANDA

10/12/2018 - 18:28

PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]

Synergy CHC Corp. Announces Insider Buying

10/12/2018 - 18:06

Westbrook, Maine, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, announced today that Synergy’s CEO and Chairman, Jack Ross [...]

OSE Immunotherapeutics Invited to Present Mechanistic Data on Clinical Stage Anti-Interleukin-7 Receptor Antagonist OSE-127 at Two International Scientific Conferences

10/12/2018 - 18:00

Data presented at the Annual World Congress of Digestive Disease in Rome, Nov. 30 - Dec. 2, and at the Antigen-Specific Immune Tolerance Europe Summit in London, Dec. 10 - 12 Presentations highlight OSE-127's [...]

Franciscan Health Doctor Named Purdue Athletics Head Team Physician

10/12/2018 - 17:59

WEST LAFAYETTE, Indiana , Dec. 10, 2018 (GLOBE NEWSWIRE) -- Purdue University’s athletic squads have a new team member to assist in providing each student-athlete a state-of-the-art system of medical care. Carly Day, MD [...]

Wildflower Begins On-Demand Delivery Service in Los Angeles

10/12/2018 - 17:51

VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), through its licensed cannabis retailer, is excited to announce that it launched delivery [...]

BioStem Technologies Releases Third Quarter 2018 Shareholder Update

10/12/2018 - 17:48

Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative technologies with a [...]

Dextran Products Wins Awards for Water Conservation Efforts

10/12/2018 - 17:03

TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC MKTS:POLXF) (the “Company”) operating as Dextran Products , today announced it has received two awards for water conservation efforts. For [...]

Ossur Hf : Transactions in relation to share buyback program

10/12/2018 - 17:01

Announcement no. 70/2018 10 December 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine

10/12/2018 - 16:31

DUBLIN - December 10, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes magazine and JUST [...]

111, Inc. Hosts Online Pharmaceuticals and Healthcare Summit to Look at the Future of Healthcare in China in the Internet Age

10/12/2018 - 16:11

SHANGHAI, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, hosted the 2018 China Online Pharmaceuticals and [...]

Merit Medical Ireland Wins Medtech Company of the Year Award 2018

10/12/2018 - 15:25

SOUTH JORDAN, Utah, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

CTD Holdings to Present at Brains for Brain Conference on Lysosomal Storage Diseases

10/12/2018 - 15:11

Annual conference offers opportunities for academic researchers and industry representatives to exchange information on novel therapeutic interventions ALACHUA, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc [...]

NeoGenomics Completes Acquisition of Genoptix, Inc.

10/12/2018 - 15:10

FT. MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent [...]

B. Braun’s Innovative Compounding System Installed at Texas Children’s Hospital

10/12/2018 - 15:02

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. successfully installed its new and innovative macro and micro APEX ® Compounding System at Texas Children’s Hospital in Houston, Texas. The [...]

Financial calendar for Zealand Pharma in 2019

10/12/2018 - 15:00

Company announcement – No. 30/2018 Financial calendar for Zealand Pharma in 2019 Copenhagen, December 10, 2018 – Zealand Pharma A/S (“ZEAL”) announces the following dates for the company's planned financial reporting in [...]

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

10/12/2018 - 15:00

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE [...]